Glecirasib (Compound 1-2, JAB-21822) is an orally active and potent inhibitor of KRAS G12C. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. Glecirasib has the potential for the research of KRAS G12C-mediated cancer[1][2][3][4].
Molekulargewicht:
640.03
Reinheit:
99.20
CAS Nummer:
[2657613-87-9]
Formel:
C31H26ClF4N7O2
Target-Kategorie:
Ras
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten